Inicio
Resultado de la búsqueda
1 búsqueda de la palabra clave 'prone position'
Clasificado(s) por (Año de edición descendente) Refinar búsqueda Genera el flujo rss de la búsqueda
Enlace permanente de la investigación
Early Use of Adjunctive Therapies for Pediatric Acute Respiratory Distress Syndrome: A PARDIE Study / Byron Enrique Piñeres Olave
Título : Early Use of Adjunctive Therapies for Pediatric Acute Respiratory Distress Syndrome: A PARDIE Study Tipo de documento : documento electrónico Autores : Byron Enrique Piñeres Olave, Fecha de publicación : 2020 Títulos uniformes : American Journal of Respiratory and Critical Care Medicine Idioma : Inglés (eng) Palabras clave : Acute Respiratory Distress syndrome extracorporeal membrane oxygenation neuromuscular blocking agents nitric oxide prone position Resumen : Rationale: Little data exist to guide early adjunctive therapy use in pediatric acute respiratory distress syndrome (PARDS). Objective: To describe contemporary use of adjunctive therapies for early PARDS as a framework for future investigations. Methods: Pre-planned, sub-study of a prospective, international, cross-sectional observational study of children with PARDS from 100 centers over 10 study weeks. Measurements and main results: We investigated six adjunctive therapies for PARDS: continuous neuromuscular blockade (cNMB), corticosteroids, inhaled nitric oxide (iNO), prone positioning, high frequency oscillatory ventilation (HFOV), and extracorporeal membrane oxygenation (ECMO). Almost half (45%) of children with PARDS received at least one therapy. Variability was noted in the median starting oxygenation index (OI) of each therapy; corticosteroids started at the lowest OI (13.0 IQR:7.6, 22.0) and HFOV at the highest (25.7 IQR:16.7, 37.3). Continuous NMB was the most common, used in 31%, followed by iNO (13%), corticosteroids (10%), prone positioning (10%), HFOV (9%), and ECMO (3%). Steroids, iNO, and HFOV were associated with comorbidities. Prone positioning and HFOV were more common in middle-income countries and less frequently used in North America. The use of multiple ancillary therapies increased over the first 3 days of PARDS, but there was not an easily identifiable pattern of combination or order of use. Conclusions: The contemporary description of prevalence, combinations of therapies and oxygenation threshold for which the therapies are applied is important for design of future studies. Region of the world, income and comorbidities influence adjunctive therapy use and are important variables to include in PARDS investigations. Mención de responsabilidad : Courtney M Rowan, Margaret J Klein, Deyin Doreen Hsing, Mary K Dahmer, Philip C Spinella, Guillaume Emeriaud, Amanda B Hassinger, Byron E Piñeres-Olave, Heidi R Flori, Bereketeab Haileselassie, Yolanda M Lopez-Fernandez, Ranjit S Chima, Steven L Shein, Aline B Maddux, Jon Lillie, Ledys Izquierdo, Martin C J Kneyber, Lincoln S Smith, Robinder G Khemani, Neal J Thomas, Nadir Yehya Referencia : Am J Respir Crit Care Med. 2020 Jun 1;201(11):1389-1397. DOI (Digital Object Identifier) : 10.1164/rccm.201909-1807OC PMID : 32130867 En línea : https://www.atsjournals.org/doi/abs/10.1164/rccm.201909-1807OC Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5089 Early Use of Adjunctive Therapies for Pediatric Acute Respiratory Distress Syndrome: A PARDIE Study [documento electrónico] / Byron Enrique Piñeres Olave, . - 2020.
Obra : American Journal of Respiratory and Critical Care Medicine
Idioma : Inglés (eng)
Palabras clave : Acute Respiratory Distress syndrome extracorporeal membrane oxygenation neuromuscular blocking agents nitric oxide prone position Resumen : Rationale: Little data exist to guide early adjunctive therapy use in pediatric acute respiratory distress syndrome (PARDS). Objective: To describe contemporary use of adjunctive therapies for early PARDS as a framework for future investigations. Methods: Pre-planned, sub-study of a prospective, international, cross-sectional observational study of children with PARDS from 100 centers over 10 study weeks. Measurements and main results: We investigated six adjunctive therapies for PARDS: continuous neuromuscular blockade (cNMB), corticosteroids, inhaled nitric oxide (iNO), prone positioning, high frequency oscillatory ventilation (HFOV), and extracorporeal membrane oxygenation (ECMO). Almost half (45%) of children with PARDS received at least one therapy. Variability was noted in the median starting oxygenation index (OI) of each therapy; corticosteroids started at the lowest OI (13.0 IQR:7.6, 22.0) and HFOV at the highest (25.7 IQR:16.7, 37.3). Continuous NMB was the most common, used in 31%, followed by iNO (13%), corticosteroids (10%), prone positioning (10%), HFOV (9%), and ECMO (3%). Steroids, iNO, and HFOV were associated with comorbidities. Prone positioning and HFOV were more common in middle-income countries and less frequently used in North America. The use of multiple ancillary therapies increased over the first 3 days of PARDS, but there was not an easily identifiable pattern of combination or order of use. Conclusions: The contemporary description of prevalence, combinations of therapies and oxygenation threshold for which the therapies are applied is important for design of future studies. Region of the world, income and comorbidities influence adjunctive therapy use and are important variables to include in PARDS investigations. Mención de responsabilidad : Courtney M Rowan, Margaret J Klein, Deyin Doreen Hsing, Mary K Dahmer, Philip C Spinella, Guillaume Emeriaud, Amanda B Hassinger, Byron E Piñeres-Olave, Heidi R Flori, Bereketeab Haileselassie, Yolanda M Lopez-Fernandez, Ranjit S Chima, Steven L Shein, Aline B Maddux, Jon Lillie, Ledys Izquierdo, Martin C J Kneyber, Lincoln S Smith, Robinder G Khemani, Neal J Thomas, Nadir Yehya Referencia : Am J Respir Crit Care Med. 2020 Jun 1;201(11):1389-1397. DOI (Digital Object Identifier) : 10.1164/rccm.201909-1807OC PMID : 32130867 En línea : https://www.atsjournals.org/doi/abs/10.1164/rccm.201909-1807OC Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5089 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD001319 AC-2020-023 Archivo digital Producción Científica Artículos científicos Disponible